Model‐based Drug Development View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2007-07

AUTHORS

R L Lalonde, K G Kowalski, M M Hutmacher, W Ewy, D J Nichols, P A Milligan, B W Corrigan, P A Lockwood, S A Marshall, L J Benincosa, T G Tensfeldt, K Parivar, M Amantea, P Glue, H Koide, R Miller

ABSTRACT

The low productivity and escalating costs of drug development have been well documented over the past several years. Less than 10% of new compounds that enter clinical trials ultimately make it to the market, and many more fail in the preclinical stages of development. These challenges in the "critical path" of drug development are discussed in a 2004 publication by the US Food and Drug Administration. The document emphasizes new tools and various opportunities to improve drug development. One of the opportunities recommended is the application of "model-based drug development (MBDD)." This paper discusses what constitutes the key elements of MBDD and how these elements should fit together to inform drug development strategy and decision-making. More... »

PAGES

21-32

References to SciGraph publications

  • 2005-09. Impact of pharmacometrics on drug approval and labeling decisions: A survey of 42 new drug applications in THE AAPS JOURNAL
  • 2006-02. Role of Mechanistically-Based Pharmacokinetic/Pharmacodynamic Models in Drug Development in CLINICAL PHARMACOKINETICS
  • 2005-04. How Modeling and Simulation Have Enhanced Decision Making in New Drug Development in JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
  • 2004-08. Can the pharmaceutical industry reduce attrition rates? in NATURE REVIEWS DRUG DISCOVERY
  • 1997-08. An Evaluation of the Integration of Pharmacokinetic and Pharmacodynamic Principles in Clinical Drug Development in CLINICAL PHARMACOKINETICS
  • 2002. Adaptive Bayesian Designs for Dose-Ranging Drug Trials in CASE STUDIES IN BAYESIAN STATISTICS VOLUME V
  • 1997-03. Learning versus confirming in clinical drug development in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 2005-09. Model-based development of gemcabene, a new lipid-altering agent in THE AAPS JOURNAL
  • 1992-04. Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug development in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 2006-09. Application of Clinical Trial Simulation to Compare Proof-of-Concept Study Designs for Drugs with a Slow Onset of Effect; An Example in Alzheimer's Disease in PHARMACEUTICAL RESEARCH
  • 2007-02. Impact of Pharmacometric Reviews on New Drug Approval and Labeling Decisions—a Survey of 31 New Drug Applications Submitted Between 2005 and 2006 in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 2006-06. Model-Based Drug Development: The Road to Quantitative Pharmacology in JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/sj.clpt.6100235

    DOI

    http://dx.doi.org/10.1038/sj.clpt.6100235

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1043146976

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/17522597


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1115", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Pharmacology and Pharmaceutical Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Alzheimer Disease", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Amines", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Analgesics", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Animals", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Anticholesteremic Agents", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Bridged Bicyclo Compounds, Heterocyclic", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Caproates", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cholesterol", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Clinical Trials as Topic", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cognition", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Computer Simulation", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cyclohexanecarboxylic Acids", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Dose-Response Relationship, Drug", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Drug Approval", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Drug Design", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Glycoproteins", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Guidelines as Topic", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Hydroxymethylglutaryl-CoA Reductase Inhibitors", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Hypercholesterolemia", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Immunologic Factors", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Meta-Analysis as Topic", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Models, Biological", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Models, Statistical", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Muscarinic Agonists", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Neuralgia, Postherpetic", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Neutrophil Infiltration", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Oximes", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Pharmacokinetics", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Pharmacology", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Reproducibility of Results", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Research Design", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Stroke", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "United States", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "United States Food and Drug Administration", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "gamma-Aminobutyric Acid", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Pfizer (United States)", 
              "id": "https://www.grid.ac/institutes/grid.410513.2", 
              "name": [
                "Pfizer Global Research and Development Department of Clinical Pharmacology Groton, Ann Arbor, Sandwich, New York La Jolla Tokyo"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Lalonde", 
            "givenName": "R L", 
            "id": "sg:person.016425161222.03", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016425161222.03"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Pfizer (United States)", 
              "id": "https://www.grid.ac/institutes/grid.410513.2", 
              "name": [
                "Pfizer Global Research and Development Department of Statistics Groton, Ann Arbor, Sandwich, New York La Jolla Tokyo"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kowalski", 
            "givenName": "K G", 
            "id": "sg:person.0714517223.48", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0714517223.48"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Pfizer (United States)", 
              "id": "https://www.grid.ac/institutes/grid.410513.2", 
              "name": [
                "Pfizer Global Research and Development Department of Clinical Pharmacology Groton, Ann Arbor, Sandwich, New York La Jolla Tokyo"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Hutmacher", 
            "givenName": "M M", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Pfizer (United States)", 
              "id": "https://www.grid.ac/institutes/grid.410513.2", 
              "name": [
                "Pfizer Global Research and Development Department of Statistics Groton, Ann Arbor, Sandwich, New York La Jolla Tokyo"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Ewy", 
            "givenName": "W", 
            "id": "sg:person.01323371463.26", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01323371463.26"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Pfizer (United States)", 
              "id": "https://www.grid.ac/institutes/grid.410513.2", 
              "name": [
                "Pfizer Global Research and Development Department of Clinical Pharmacology Groton, Ann Arbor, Sandwich, New York La Jolla Tokyo"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Nichols", 
            "givenName": "D J", 
            "id": "sg:person.0776376602.70", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0776376602.70"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Pfizer (United States)", 
              "id": "https://www.grid.ac/institutes/grid.410513.2", 
              "name": [
                "Pfizer Global Research and Development Department of Clinical Pharmacology Groton, Ann Arbor, Sandwich, New York La Jolla Tokyo"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Milligan", 
            "givenName": "P A", 
            "id": "sg:person.0650413757.63", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0650413757.63"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Pfizer (United States)", 
              "id": "https://www.grid.ac/institutes/grid.410513.2", 
              "name": [
                "Pfizer Global Research and Development Department of Clinical Pharmacology Groton, Ann Arbor, Sandwich, New York La Jolla Tokyo"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Corrigan", 
            "givenName": "B W", 
            "id": "sg:person.01371504663.54", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01371504663.54"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Pfizer (United States)", 
              "id": "https://www.grid.ac/institutes/grid.410513.2", 
              "name": [
                "Pfizer Global Research and Development Department of Clinical Pharmacology Groton, Ann Arbor, Sandwich, New York La Jolla Tokyo"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Lockwood", 
            "givenName": "P A", 
            "id": "sg:person.0762632423.80", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0762632423.80"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Pfizer (United States)", 
              "id": "https://www.grid.ac/institutes/grid.410513.2", 
              "name": [
                "Pfizer Global Research and Development Department of Clinical Pharmacology Groton, Ann Arbor, Sandwich, New York La Jolla Tokyo"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Marshall", 
            "givenName": "S A", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Pfizer (United States)", 
              "id": "https://www.grid.ac/institutes/grid.410513.2", 
              "name": [
                "Pfizer Global Research and Development Department of Clinical Pharmacology Groton, Ann Arbor, Sandwich, New York La Jolla Tokyo"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Benincosa", 
            "givenName": "L J", 
            "id": "sg:person.0765673230.47", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0765673230.47"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Pfizer (United States)", 
              "id": "https://www.grid.ac/institutes/grid.410513.2", 
              "name": [
                "Pfizer Global Research and Development Department of Clinical Pharmacology Groton, Ann Arbor, Sandwich, New York La Jolla Tokyo"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Tensfeldt", 
            "givenName": "T G", 
            "id": "sg:person.0707247741.17", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0707247741.17"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Pfizer (United States)", 
              "id": "https://www.grid.ac/institutes/grid.410513.2", 
              "name": [
                "Pfizer Global Research and Development Department of Clinical Pharmacology Groton, Ann Arbor, Sandwich, New York La Jolla Tokyo"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Parivar", 
            "givenName": "K", 
            "id": "sg:person.01366010377.60", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01366010377.60"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Pfizer (United States)", 
              "id": "https://www.grid.ac/institutes/grid.410513.2", 
              "name": [
                "Pfizer Global Research and Development Department of Clinical Pharmacology Groton, Ann Arbor, Sandwich, New York La Jolla Tokyo"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Amantea", 
            "givenName": "M", 
            "id": "sg:person.0644756652.28", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0644756652.28"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Pfizer (United States)", 
              "id": "https://www.grid.ac/institutes/grid.410513.2", 
              "name": [
                "Pfizer Global Research and Development Department of Clinical Pharmacology Groton, Ann Arbor, Sandwich, New York La Jolla Tokyo"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Glue", 
            "givenName": "P", 
            "id": "sg:person.01044525577.06", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01044525577.06"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Pfizer (United States)", 
              "id": "https://www.grid.ac/institutes/grid.410513.2", 
              "name": [
                "Pfizer Global Research and Development Department of Clinical Pharmacology Groton, Ann Arbor, Sandwich, New York La Jolla Tokyo"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Koide", 
            "givenName": "H", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Pfizer (United States)", 
              "id": "https://www.grid.ac/institutes/grid.410513.2", 
              "name": [
                "Pfizer Global Research and Development Department of Clinical Pharmacology Groton, Ann Arbor, Sandwich, New York La Jolla Tokyo"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Miller", 
            "givenName": "R", 
            "id": "sg:person.01035214012.08", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01035214012.08"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "https://doi.org/10.1201/9780203910276.ch4", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1001491954"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/s0140-6736(01)06711-3", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1001563538"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1080/10543400600860535", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1005015180"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.clpt.6100051", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1007052083", 
              "https://doi.org/10.1038/sj.clpt.6100051"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.clpt.6100051", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1007052083", 
              "https://doi.org/10.1038/sj.clpt.6100051"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/978-1-4613-0035-9_2", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1012530363", 
              "https://doi.org/10.1007/978-1-4613-0035-9_2"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/978-1-4613-0035-9_2", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1012530363", 
              "https://doi.org/10.1007/978-1-4613-0035-9_2"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1146/annurev.pharmtox.40.1.67", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1014703851"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.2165/00003088-200645020-00004", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1018813613", 
              "https://doi.org/10.2165/00003088-200645020-00004"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.2165/00003088-200645020-00004", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1018813613", 
              "https://doi.org/10.2165/00003088-200645020-00004"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.2165/00003088-200645020-00004", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1018813613", 
              "https://doi.org/10.2165/00003088-200645020-00004"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1208/aapsj070352", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1020664380", 
              "https://doi.org/10.1208/aapsj070352"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.2165/00003088-199733020-00005", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1022683225", 
              "https://doi.org/10.2165/00003088-199733020-00005"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.2165/00003088-199733020-00005", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1022683225", 
              "https://doi.org/10.2165/00003088-199733020-00005"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1111/j.1468-2982.2004.00939.x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1025621249"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1111/j.1468-2982.2004.00939.x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1025621249"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s11095-006-9048-8", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1031456205", 
              "https://doi.org/10.1007/s11095-006-9048-8"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1016/s0009-9236(97)90160-0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1031926675", 
              "https://doi.org/10.1016/s0009-9236(97)90160-0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s10928-005-0074-7", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1034445198", 
              "https://doi.org/10.1007/s10928-005-0074-7"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s10928-005-0074-7", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1034445198", 
              "https://doi.org/10.1007/s10928-005-0074-7"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/0197-2456(86)90046-2", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1034546744"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/0197-2456(86)90046-2", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1034546744"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s10928-006-9010-8", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1035357317", 
              "https://doi.org/10.1007/s10928-006-9010-8"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1161/01.cir.0000133317.49796.0e", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1035818241"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1161/01.str.0000092527.33910.89", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1036182363"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1161/01.str.0000092527.33910.89", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1036182363"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/s0304-3959(01)00349-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1039541235"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/s0304-3959(01)00349-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1039541235"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrd1470", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1041019353", 
              "https://doi.org/10.1038/nrd1470"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrd1470", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1041019353", 
              "https://doi.org/10.1038/nrd1470"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/clpt.1992.47", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1041049065", 
              "https://doi.org/10.1038/clpt.1992.47"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1046/j.1468-2982.2002.00404.x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1041457607"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1046/j.1468-2982.2002.00404.x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1041457607"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1073/pnas.89.23.11471", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1042155515"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1146/annurev.pharmtox.40.1.209", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1050091365"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1146/annurev.pharmtox.41.1.625", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1051568518"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1208/aapsj070351", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1052268149", 
              "https://doi.org/10.1208/aapsj070351"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2007-07", 
        "datePublishedReg": "2007-07-01", 
        "description": "The low productivity and escalating costs of drug development have been well documented over the past several years. Less than 10% of new compounds that enter clinical trials ultimately make it to the market, and many more fail in the preclinical stages of development. These challenges in the \"critical path\" of drug development are discussed in a 2004 publication by the US Food and Drug Administration. The document emphasizes new tools and various opportunities to improve drug development. One of the opportunities recommended is the application of \"model-based drug development (MBDD).\" This paper discusses what constitutes the key elements of MBDD and how these elements should fit together to inform drug development strategy and decision-making.", 
        "genre": "research_article", 
        "id": "sg:pub.10.1038/sj.clpt.6100235", 
        "inLanguage": [
          "en"
        ], 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1017409", 
            "issn": [
              "0009-9236", 
              "1532-6535"
            ], 
            "name": "Clinical Pharmacology & Therapeutics", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "1", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "82"
          }
        ], 
        "name": "Model\u2010based Drug Development", 
        "pagination": "21-32", 
        "productId": [
          {
            "name": "readcube_id", 
            "type": "PropertyValue", 
            "value": [
              "cd860975cfc446e74bd3ab3d3ff8b64c29454c63f4872456493ac566f75bab71"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "17522597"
            ]
          }, 
          {
            "name": "nlm_unique_id", 
            "type": "PropertyValue", 
            "value": [
              "0372741"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/sj.clpt.6100235"
            ]
          }, 
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1043146976"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/sj.clpt.6100235", 
          "https://app.dimensions.ai/details/publication/pub.1043146976"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2019-04-10T20:22", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8684_00000270.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "http://onlinelibrary.wiley.com/doi/10.1038/sj.clpt.6100235/abstract"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.clpt.6100235'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.clpt.6100235'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.clpt.6100235'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.clpt.6100235'


     

    This table displays all metadata directly associated to this object as RDF triples.

    403 TRIPLES      21 PREDICATES      90 URIs      57 LITERALS      45 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/sj.clpt.6100235 schema:about N00bfc3aa0dc14d23b68bccfe3cf129d9
    2 N077658d5b05f4859a6cb01e7801a2c4e
    3 N15541c773cf142c89fb3a4241e458720
    4 N158550b8465843ab8f72f6249dd8c6e4
    5 N19aabb1608bf458b87fc45c15a8be3e4
    6 N1afe7ff32d1a47b9b421825217016bfe
    7 N21ddeb1b0bf24dd0b79bce821277184b
    8 N26ad08ca738b4639bea52049549948ad
    9 N3218a75c04bb46e1b3415bae7a5f5599
    10 N348ee50753ea4d7a9ccf1beb875baddd
    11 N3f0c98fc80d84d0fb32e1fb30eaf6fa0
    12 N43f3a3cceb9f4540b83dff53c54af427
    13 N45a2093cc46844c2ae5cd103e67ad911
    14 N699ec0e4ecd74ba686c7344acb4fbcc8
    15 N7829e012bcbf428b8bec659239325709
    16 N7834488516fe4d599eaab7ea6e882adb
    17 N8262ac6754724041bdd61db9c016e803
    18 N9a7cfb14771d45b9813b9d3788545461
    19 N9e49392284a74d0ca98c5528f053f08c
    20 Na5f38a871d854277960ad02be7aba305
    21 Na91f86a5dcd24ed39fda3acb5dbb6cf4
    22 Naa83aae8a1df4c538c3e368c5603df65
    23 Nabd80ba8f7244015a7c720ba71717e4a
    24 Nbe9c8177280e404fb2eea40dd950d101
    25 Nc1943d6110b24f8687847660cc2c4ac3
    26 Nc326f8a6bc334253bc02bef15bf557fe
    27 Ncf4020a85651455794c7695f3ce42978
    28 Nd10245aeffe046e3bcb173fa74b9bcaf
    29 Nd295f5b33b1f4fc48c9e1caa4e3cc0cd
    30 Ne139d0619d84431da41ec02990e331e3
    31 Ne58765fa7a2b4ea1aff6a8348595e561
    32 Nef3af1d78e894e3eac2ef695c5bac81c
    33 Nf6c94d5adb4f49c8b6a2a6b63ddfb3fb
    34 Nf6cea25418ce40678be120d286758ef8
    35 Nf7a4f9416fcf41fea4346152cb61d393
    36 Nffde78327cff46e5a58d76ca3c534c2b
    37 anzsrc-for:11
    38 anzsrc-for:1115
    39 schema:author N845136731ab641b5b67fb7f27e4f1efa
    40 schema:citation sg:pub.10.1007/978-1-4613-0035-9_2
    41 sg:pub.10.1007/s10928-005-0074-7
    42 sg:pub.10.1007/s10928-006-9010-8
    43 sg:pub.10.1007/s11095-006-9048-8
    44 sg:pub.10.1016/s0009-9236(97)90160-0
    45 sg:pub.10.1038/clpt.1992.47
    46 sg:pub.10.1038/nrd1470
    47 sg:pub.10.1038/sj.clpt.6100051
    48 sg:pub.10.1208/aapsj070351
    49 sg:pub.10.1208/aapsj070352
    50 sg:pub.10.2165/00003088-199733020-00005
    51 sg:pub.10.2165/00003088-200645020-00004
    52 https://doi.org/10.1016/0197-2456(86)90046-2
    53 https://doi.org/10.1016/s0140-6736(01)06711-3
    54 https://doi.org/10.1016/s0304-3959(01)00349-9
    55 https://doi.org/10.1046/j.1468-2982.2002.00404.x
    56 https://doi.org/10.1073/pnas.89.23.11471
    57 https://doi.org/10.1080/10543400600860535
    58 https://doi.org/10.1111/j.1468-2982.2004.00939.x
    59 https://doi.org/10.1146/annurev.pharmtox.40.1.209
    60 https://doi.org/10.1146/annurev.pharmtox.40.1.67
    61 https://doi.org/10.1146/annurev.pharmtox.41.1.625
    62 https://doi.org/10.1161/01.cir.0000133317.49796.0e
    63 https://doi.org/10.1161/01.str.0000092527.33910.89
    64 https://doi.org/10.1201/9780203910276.ch4
    65 schema:datePublished 2007-07
    66 schema:datePublishedReg 2007-07-01
    67 schema:description The low productivity and escalating costs of drug development have been well documented over the past several years. Less than 10% of new compounds that enter clinical trials ultimately make it to the market, and many more fail in the preclinical stages of development. These challenges in the "critical path" of drug development are discussed in a 2004 publication by the US Food and Drug Administration. The document emphasizes new tools and various opportunities to improve drug development. One of the opportunities recommended is the application of "model-based drug development (MBDD)." This paper discusses what constitutes the key elements of MBDD and how these elements should fit together to inform drug development strategy and decision-making.
    68 schema:genre research_article
    69 schema:inLanguage en
    70 schema:isAccessibleForFree false
    71 schema:isPartOf N2541497ae61344058a58f45773ff4d2f
    72 Ndc35aba0ac2849cea825be38c25bf18d
    73 sg:journal.1017409
    74 schema:name Model‐based Drug Development
    75 schema:pagination 21-32
    76 schema:productId N220a6731a71e4883a427b2675bb8edd9
    77 N5bc9864f56b2412c9996846d5a5df9a6
    78 N5eeb6b8afe6b47a28130d050b37d3fd6
    79 Nd60abe4c126d48a9aff83f86d0430df5
    80 Nf76b748f367745918e7a7b6aace8115d
    81 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043146976
    82 https://doi.org/10.1038/sj.clpt.6100235
    83 schema:sdDatePublished 2019-04-10T20:22
    84 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    85 schema:sdPublisher N4ac0adc71596429bafc0fd5aa27cca37
    86 schema:url http://onlinelibrary.wiley.com/doi/10.1038/sj.clpt.6100235/abstract
    87 sgo:license sg:explorer/license/
    88 sgo:sdDataset articles
    89 rdf:type schema:ScholarlyArticle
    90 N00bfc3aa0dc14d23b68bccfe3cf129d9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    91 schema:name Caproates
    92 rdf:type schema:DefinedTerm
    93 N077658d5b05f4859a6cb01e7801a2c4e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    94 schema:name Muscarinic Agonists
    95 rdf:type schema:DefinedTerm
    96 N15541c773cf142c89fb3a4241e458720 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    97 schema:name Models, Biological
    98 rdf:type schema:DefinedTerm
    99 N158550b8465843ab8f72f6249dd8c6e4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    100 schema:name Drug Approval
    101 rdf:type schema:DefinedTerm
    102 N1701b59aab2b484ab0e53ed50f33650b rdf:first sg:person.01323371463.26
    103 rdf:rest Nbc6fdbb7fbf34e898f934ee6a548a2f7
    104 N19aabb1608bf458b87fc45c15a8be3e4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    105 schema:name Computer Simulation
    106 rdf:type schema:DefinedTerm
    107 N1afe7ff32d1a47b9b421825217016bfe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    108 schema:name Anticholesteremic Agents
    109 rdf:type schema:DefinedTerm
    110 N1d2bd0d65f71495fad9c55bd7450a011 rdf:first sg:person.0714517223.48
    111 rdf:rest Na76dff9afa87421484e39c91a4e16051
    112 N21ddeb1b0bf24dd0b79bce821277184b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    113 schema:name Guidelines as Topic
    114 rdf:type schema:DefinedTerm
    115 N220a6731a71e4883a427b2675bb8edd9 schema:name nlm_unique_id
    116 schema:value 0372741
    117 rdf:type schema:PropertyValue
    118 N2541497ae61344058a58f45773ff4d2f schema:issueNumber 1
    119 rdf:type schema:PublicationIssue
    120 N26ad08ca738b4639bea52049549948ad schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    121 schema:name Alzheimer Disease
    122 rdf:type schema:DefinedTerm
    123 N320bd3eddb0e4cb9a262ee6936c3094f rdf:first Nc094cc2fce4c434dbceef13f90cd556a
    124 rdf:rest N34e1d2fafabd4775a71422a809557f7b
    125 N3218a75c04bb46e1b3415bae7a5f5599 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    126 schema:name gamma-Aminobutyric Acid
    127 rdf:type schema:DefinedTerm
    128 N348ee50753ea4d7a9ccf1beb875baddd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    129 schema:name Pharmacokinetics
    130 rdf:type schema:DefinedTerm
    131 N34e1d2fafabd4775a71422a809557f7b rdf:first sg:person.0765673230.47
    132 rdf:rest Nc3891006bcdf46d5accf0c09b1bb9f9a
    133 N3616da4e74db43dcb19423a4ceec6eb6 rdf:first sg:person.0650413757.63
    134 rdf:rest Nfe0b56a083fe44aea6a36901001a8b17
    135 N3f0c98fc80d84d0fb32e1fb30eaf6fa0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    136 schema:name Models, Statistical
    137 rdf:type schema:DefinedTerm
    138 N43f3a3cceb9f4540b83dff53c54af427 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    139 schema:name Pharmacology
    140 rdf:type schema:DefinedTerm
    141 N45a2093cc46844c2ae5cd103e67ad911 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    142 schema:name Neutrophil Infiltration
    143 rdf:type schema:DefinedTerm
    144 N4ac0adc71596429bafc0fd5aa27cca37 schema:name Springer Nature - SN SciGraph project
    145 rdf:type schema:Organization
    146 N5bc9864f56b2412c9996846d5a5df9a6 schema:name doi
    147 schema:value 10.1038/sj.clpt.6100235
    148 rdf:type schema:PropertyValue
    149 N5eeb6b8afe6b47a28130d050b37d3fd6 schema:name readcube_id
    150 schema:value cd860975cfc446e74bd3ab3d3ff8b64c29454c63f4872456493ac566f75bab71
    151 rdf:type schema:PropertyValue
    152 N699ec0e4ecd74ba686c7344acb4fbcc8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    153 schema:name Humans
    154 rdf:type schema:DefinedTerm
    155 N7829e012bcbf428b8bec659239325709 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    156 schema:name Reproducibility of Results
    157 rdf:type schema:DefinedTerm
    158 N7834488516fe4d599eaab7ea6e882adb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    159 schema:name Hypercholesterolemia
    160 rdf:type schema:DefinedTerm
    161 N8262ac6754724041bdd61db9c016e803 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    162 schema:name Research Design
    163 rdf:type schema:DefinedTerm
    164 N845136731ab641b5b67fb7f27e4f1efa rdf:first sg:person.016425161222.03
    165 rdf:rest N1d2bd0d65f71495fad9c55bd7450a011
    166 N9a7cfb14771d45b9813b9d3788545461 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    167 schema:name Cognition
    168 rdf:type schema:DefinedTerm
    169 N9e49392284a74d0ca98c5528f053f08c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    170 schema:name Glycoproteins
    171 rdf:type schema:DefinedTerm
    172 Na5916e58f1f84c67a0e8c1f470480cd1 rdf:first sg:person.0762632423.80
    173 rdf:rest N320bd3eddb0e4cb9a262ee6936c3094f
    174 Na5f38a871d854277960ad02be7aba305 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    175 schema:name Amines
    176 rdf:type schema:DefinedTerm
    177 Na76dff9afa87421484e39c91a4e16051 rdf:first Nc5c041345a4d4514b0bfdda9c08e5efd
    178 rdf:rest N1701b59aab2b484ab0e53ed50f33650b
    179 Na91f86a5dcd24ed39fda3acb5dbb6cf4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    180 schema:name Clinical Trials as Topic
    181 rdf:type schema:DefinedTerm
    182 Naa83aae8a1df4c538c3e368c5603df65 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    183 schema:name Analgesics
    184 rdf:type schema:DefinedTerm
    185 Nabd80ba8f7244015a7c720ba71717e4a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    186 schema:name Hydroxymethylglutaryl-CoA Reductase Inhibitors
    187 rdf:type schema:DefinedTerm
    188 Nac327005948c4582ba2db9a3fa68f8af rdf:first sg:person.0644756652.28
    189 rdf:rest Nf14e92b1dfbd4e3d849a29ecb558f226
    190 Nbc6fdbb7fbf34e898f934ee6a548a2f7 rdf:first sg:person.0776376602.70
    191 rdf:rest N3616da4e74db43dcb19423a4ceec6eb6
    192 Nbe9c8177280e404fb2eea40dd950d101 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    193 schema:name Immunologic Factors
    194 rdf:type schema:DefinedTerm
    195 Nc0338b479738418b92f8f5ad2d9e7ec8 rdf:first Nea6ab9950fb64938a8ccb996be4b545c
    196 rdf:rest Nc76aa46555724e79b5d38b7f01b3b135
    197 Nc094cc2fce4c434dbceef13f90cd556a schema:affiliation https://www.grid.ac/institutes/grid.410513.2
    198 schema:familyName Marshall
    199 schema:givenName S A
    200 rdf:type schema:Person
    201 Nc1943d6110b24f8687847660cc2c4ac3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    202 schema:name Neuralgia, Postherpetic
    203 rdf:type schema:DefinedTerm
    204 Nc326f8a6bc334253bc02bef15bf557fe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    205 schema:name Meta-Analysis as Topic
    206 rdf:type schema:DefinedTerm
    207 Nc3891006bcdf46d5accf0c09b1bb9f9a rdf:first sg:person.0707247741.17
    208 rdf:rest Ncdf4534925594d14b059efecda6bc3c5
    209 Nc5c041345a4d4514b0bfdda9c08e5efd schema:affiliation https://www.grid.ac/institutes/grid.410513.2
    210 schema:familyName Hutmacher
    211 schema:givenName M M
    212 rdf:type schema:Person
    213 Nc76aa46555724e79b5d38b7f01b3b135 rdf:first sg:person.01035214012.08
    214 rdf:rest rdf:nil
    215 Ncdf4534925594d14b059efecda6bc3c5 rdf:first sg:person.01366010377.60
    216 rdf:rest Nac327005948c4582ba2db9a3fa68f8af
    217 Ncf4020a85651455794c7695f3ce42978 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    218 schema:name Drug Design
    219 rdf:type schema:DefinedTerm
    220 Nd10245aeffe046e3bcb173fa74b9bcaf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    221 schema:name United States
    222 rdf:type schema:DefinedTerm
    223 Nd295f5b33b1f4fc48c9e1caa4e3cc0cd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    224 schema:name Oximes
    225 rdf:type schema:DefinedTerm
    226 Nd60abe4c126d48a9aff83f86d0430df5 schema:name dimensions_id
    227 schema:value pub.1043146976
    228 rdf:type schema:PropertyValue
    229 Ndc35aba0ac2849cea825be38c25bf18d schema:volumeNumber 82
    230 rdf:type schema:PublicationVolume
    231 Ne139d0619d84431da41ec02990e331e3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    232 schema:name Bridged Bicyclo Compounds, Heterocyclic
    233 rdf:type schema:DefinedTerm
    234 Ne58765fa7a2b4ea1aff6a8348595e561 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    235 schema:name Dose-Response Relationship, Drug
    236 rdf:type schema:DefinedTerm
    237 Nea6ab9950fb64938a8ccb996be4b545c schema:affiliation https://www.grid.ac/institutes/grid.410513.2
    238 schema:familyName Koide
    239 schema:givenName H
    240 rdf:type schema:Person
    241 Nef3af1d78e894e3eac2ef695c5bac81c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    242 schema:name Cholesterol
    243 rdf:type schema:DefinedTerm
    244 Nf14e92b1dfbd4e3d849a29ecb558f226 rdf:first sg:person.01044525577.06
    245 rdf:rest Nc0338b479738418b92f8f5ad2d9e7ec8
    246 Nf6c94d5adb4f49c8b6a2a6b63ddfb3fb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    247 schema:name Cyclohexanecarboxylic Acids
    248 rdf:type schema:DefinedTerm
    249 Nf6cea25418ce40678be120d286758ef8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    250 schema:name United States Food and Drug Administration
    251 rdf:type schema:DefinedTerm
    252 Nf76b748f367745918e7a7b6aace8115d schema:name pubmed_id
    253 schema:value 17522597
    254 rdf:type schema:PropertyValue
    255 Nf7a4f9416fcf41fea4346152cb61d393 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    256 schema:name Animals
    257 rdf:type schema:DefinedTerm
    258 Nfe0b56a083fe44aea6a36901001a8b17 rdf:first sg:person.01371504663.54
    259 rdf:rest Na5916e58f1f84c67a0e8c1f470480cd1
    260 Nffde78327cff46e5a58d76ca3c534c2b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    261 schema:name Stroke
    262 rdf:type schema:DefinedTerm
    263 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    264 schema:name Medical and Health Sciences
    265 rdf:type schema:DefinedTerm
    266 anzsrc-for:1115 schema:inDefinedTermSet anzsrc-for:
    267 schema:name Pharmacology and Pharmaceutical Sciences
    268 rdf:type schema:DefinedTerm
    269 sg:journal.1017409 schema:issn 0009-9236
    270 1532-6535
    271 schema:name Clinical Pharmacology & Therapeutics
    272 rdf:type schema:Periodical
    273 sg:person.01035214012.08 schema:affiliation https://www.grid.ac/institutes/grid.410513.2
    274 schema:familyName Miller
    275 schema:givenName R
    276 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01035214012.08
    277 rdf:type schema:Person
    278 sg:person.01044525577.06 schema:affiliation https://www.grid.ac/institutes/grid.410513.2
    279 schema:familyName Glue
    280 schema:givenName P
    281 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01044525577.06
    282 rdf:type schema:Person
    283 sg:person.01323371463.26 schema:affiliation https://www.grid.ac/institutes/grid.410513.2
    284 schema:familyName Ewy
    285 schema:givenName W
    286 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01323371463.26
    287 rdf:type schema:Person
    288 sg:person.01366010377.60 schema:affiliation https://www.grid.ac/institutes/grid.410513.2
    289 schema:familyName Parivar
    290 schema:givenName K
    291 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01366010377.60
    292 rdf:type schema:Person
    293 sg:person.01371504663.54 schema:affiliation https://www.grid.ac/institutes/grid.410513.2
    294 schema:familyName Corrigan
    295 schema:givenName B W
    296 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01371504663.54
    297 rdf:type schema:Person
    298 sg:person.016425161222.03 schema:affiliation https://www.grid.ac/institutes/grid.410513.2
    299 schema:familyName Lalonde
    300 schema:givenName R L
    301 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016425161222.03
    302 rdf:type schema:Person
    303 sg:person.0644756652.28 schema:affiliation https://www.grid.ac/institutes/grid.410513.2
    304 schema:familyName Amantea
    305 schema:givenName M
    306 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0644756652.28
    307 rdf:type schema:Person
    308 sg:person.0650413757.63 schema:affiliation https://www.grid.ac/institutes/grid.410513.2
    309 schema:familyName Milligan
    310 schema:givenName P A
    311 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0650413757.63
    312 rdf:type schema:Person
    313 sg:person.0707247741.17 schema:affiliation https://www.grid.ac/institutes/grid.410513.2
    314 schema:familyName Tensfeldt
    315 schema:givenName T G
    316 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0707247741.17
    317 rdf:type schema:Person
    318 sg:person.0714517223.48 schema:affiliation https://www.grid.ac/institutes/grid.410513.2
    319 schema:familyName Kowalski
    320 schema:givenName K G
    321 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0714517223.48
    322 rdf:type schema:Person
    323 sg:person.0762632423.80 schema:affiliation https://www.grid.ac/institutes/grid.410513.2
    324 schema:familyName Lockwood
    325 schema:givenName P A
    326 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0762632423.80
    327 rdf:type schema:Person
    328 sg:person.0765673230.47 schema:affiliation https://www.grid.ac/institutes/grid.410513.2
    329 schema:familyName Benincosa
    330 schema:givenName L J
    331 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0765673230.47
    332 rdf:type schema:Person
    333 sg:person.0776376602.70 schema:affiliation https://www.grid.ac/institutes/grid.410513.2
    334 schema:familyName Nichols
    335 schema:givenName D J
    336 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0776376602.70
    337 rdf:type schema:Person
    338 sg:pub.10.1007/978-1-4613-0035-9_2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012530363
    339 https://doi.org/10.1007/978-1-4613-0035-9_2
    340 rdf:type schema:CreativeWork
    341 sg:pub.10.1007/s10928-005-0074-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034445198
    342 https://doi.org/10.1007/s10928-005-0074-7
    343 rdf:type schema:CreativeWork
    344 sg:pub.10.1007/s10928-006-9010-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035357317
    345 https://doi.org/10.1007/s10928-006-9010-8
    346 rdf:type schema:CreativeWork
    347 sg:pub.10.1007/s11095-006-9048-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031456205
    348 https://doi.org/10.1007/s11095-006-9048-8
    349 rdf:type schema:CreativeWork
    350 sg:pub.10.1016/s0009-9236(97)90160-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031926675
    351 https://doi.org/10.1016/s0009-9236(97)90160-0
    352 rdf:type schema:CreativeWork
    353 sg:pub.10.1038/clpt.1992.47 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041049065
    354 https://doi.org/10.1038/clpt.1992.47
    355 rdf:type schema:CreativeWork
    356 sg:pub.10.1038/nrd1470 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041019353
    357 https://doi.org/10.1038/nrd1470
    358 rdf:type schema:CreativeWork
    359 sg:pub.10.1038/sj.clpt.6100051 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007052083
    360 https://doi.org/10.1038/sj.clpt.6100051
    361 rdf:type schema:CreativeWork
    362 sg:pub.10.1208/aapsj070351 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052268149
    363 https://doi.org/10.1208/aapsj070351
    364 rdf:type schema:CreativeWork
    365 sg:pub.10.1208/aapsj070352 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020664380
    366 https://doi.org/10.1208/aapsj070352
    367 rdf:type schema:CreativeWork
    368 sg:pub.10.2165/00003088-199733020-00005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022683225
    369 https://doi.org/10.2165/00003088-199733020-00005
    370 rdf:type schema:CreativeWork
    371 sg:pub.10.2165/00003088-200645020-00004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018813613
    372 https://doi.org/10.2165/00003088-200645020-00004
    373 rdf:type schema:CreativeWork
    374 https://doi.org/10.1016/0197-2456(86)90046-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034546744
    375 rdf:type schema:CreativeWork
    376 https://doi.org/10.1016/s0140-6736(01)06711-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001563538
    377 rdf:type schema:CreativeWork
    378 https://doi.org/10.1016/s0304-3959(01)00349-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039541235
    379 rdf:type schema:CreativeWork
    380 https://doi.org/10.1046/j.1468-2982.2002.00404.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1041457607
    381 rdf:type schema:CreativeWork
    382 https://doi.org/10.1073/pnas.89.23.11471 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042155515
    383 rdf:type schema:CreativeWork
    384 https://doi.org/10.1080/10543400600860535 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005015180
    385 rdf:type schema:CreativeWork
    386 https://doi.org/10.1111/j.1468-2982.2004.00939.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1025621249
    387 rdf:type schema:CreativeWork
    388 https://doi.org/10.1146/annurev.pharmtox.40.1.209 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050091365
    389 rdf:type schema:CreativeWork
    390 https://doi.org/10.1146/annurev.pharmtox.40.1.67 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014703851
    391 rdf:type schema:CreativeWork
    392 https://doi.org/10.1146/annurev.pharmtox.41.1.625 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051568518
    393 rdf:type schema:CreativeWork
    394 https://doi.org/10.1161/01.cir.0000133317.49796.0e schema:sameAs https://app.dimensions.ai/details/publication/pub.1035818241
    395 rdf:type schema:CreativeWork
    396 https://doi.org/10.1161/01.str.0000092527.33910.89 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036182363
    397 rdf:type schema:CreativeWork
    398 https://doi.org/10.1201/9780203910276.ch4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001491954
    399 rdf:type schema:CreativeWork
    400 https://www.grid.ac/institutes/grid.410513.2 schema:alternateName Pfizer (United States)
    401 schema:name Pfizer Global Research and Development Department of Clinical Pharmacology Groton, Ann Arbor, Sandwich, New York La Jolla Tokyo
    402 Pfizer Global Research and Development Department of Statistics Groton, Ann Arbor, Sandwich, New York La Jolla Tokyo
    403 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...